Your browser doesn't support javascript.
loading
Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
Weng, Mao-Chi; Wang, Mei-Hui; Tsai, Jai-Jen; Kuo, Yu-Cheng; Liu, Yu-Chang; Hsu, Fei-Ting; Wang, Hsin-Ell.
Affiliation
  • Weng MC; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taiwan.
  • Wang MH; Division of Isotope Application, Institute of Nuclear Energy Research, Atomic Energy Council, Taiwan.
  • Tsai JJ; Division of Isotope Application, Institute of Nuclear Energy Research, Atomic Energy Council, Taiwan.
  • Kuo YC; Division of Gastroenterology, Department of Medicine, National Yang-Ming University Hospital, Yilan, Taiwan.
  • Liu YC; Radiation Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan.
  • Hsu FT; Department of Radiological Technology, China Medical University, Taichung, Taiwan.
  • Wang HE; Department of Radiation Oncology, National Yang-Ming University Hospital, Yilan, Taiwan.
Biosci Rep ; 38(3)2018 06 29.
Article in En | MEDLINE | ID: mdl-29535278
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / NF-kappa B / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Biosci Rep Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / NF-kappa B / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Biosci Rep Year: 2018 Document type: Article Affiliation country: Country of publication: